{
    "Trade/Device Name(s)": [
        "StatusFirst\u2122M CHF NT-proBNP"
    ],
    "Submitter Information": "Nanogen Inc.",
    "510(k) Number": "K051596",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032646"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC"
    ],
    "Summary Letter Date": "March 13, 2006",
    "Summary Letter Received Date": "February 21, 2006",
    "Submission Date": "February 17, 2006",
    "Regulation Number(s)": [
        "21CFR862.1117"
    ],
    "Regulation Name(s)": [
        "B-type natriuretic peptide test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiology",
        "misc"
    ],
    "Analyte(s)": [
        "N-terminal pro-Brain natriuretic peptide (NT-proBNP)"
    ],
    "Specimen Type(s)": [
        "EDTA plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "DXpress\u2122M Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Analyzer",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for StatusFirst\u2122M CHF NT-proBNP rapid chromatographic immunoassay for quantitative NT-proBNP determination with DXpress\u2122M Reader for congestive heart failure diagnosis.",
    "Indications for Use Summary": "A rapid in-vitro quantitative test for NT-proBNP in human EDTA plasma, intended to be used with the DXpress\u2122M Reader as an aid in the diagnosis of congestive heart failure.",
    "fda_folder": "Clinical Chemistry"
}